Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The Contribution of Immune Evasive Mechanisms to Parasite Persistence in Visceral Leishmaniasis
Elisângela Oliveira de Freitas, Fabiana M. S. Leoratti, Célio Geraldo Freire-de-Lima, et al.
Frontiers in Immunology (2016) Vol. 7
Open Access | Times Cited: 65

Showing 1-25 of 65 citing articles:

Leishmaniasis in humans: drug or vaccine therapy?
Masoud Ghorbani, Ramin Farhoudi
Drug Design Development and Therapy (2017) Vol. Volume 12, pp. 25-40
Open Access | Times Cited: 322
Macrophage Polarization in Leishmaniasis: Broadening Horizons
Fernanda Tomiotto‐Pellissier, Bruna Taciane da Silva Bortoleti, João Paulo Assolini, et al.
Frontiers in Immunology (2018) Vol. 9
Open Access | Times Cited: 188
Sex-Related Differences in Immune Response and Symptomatic Manifestations to Infection with Leishmania Species
Ryan D. Lockard, Mary E. Wilson, Nilda E. Rodríguez
Journal of Immunology Research (2019) Vol. 2019, pp. 1-14
Open Access | Times Cited: 68
Infection-adapted emergency hematopoiesis promotes visceral leishmaniasis
Belma Melda Abidin, Akil Hammami, Simona Stäger, et al.
PLoS Pathogens (2017) Vol. 13, Iss. 8, pp. e1006422-e1006422
Open Access | Times Cited: 67
Targeting Macrophage Histone H3 Modification as a Leishmania Strategy to Dampen the NF-κB/NLRP3-Mediated Inflammatory Response
Hervé Lecœur, Eric Prina, Thibault Rosazza, et al.
Cell Reports (2020) Vol. 30, Iss. 6, pp. 1870-1882.e4
Open Access | Times Cited: 65
Leishmania Spp-Host Interaction: There Is Always an Onset, but Is There an End?
Fátima Conceição‐Silva, Fernanda N. Morgado
Frontiers in Cellular and Infection Microbiology (2019) Vol. 9
Open Access | Times Cited: 62
Memory T cells: promising biomarkers for evaluating protection and vaccine efficacy against leishmaniasis
Mahmoud Nateghi Rostami, Yahya Sohrabi
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 7
Immunological factors, but not clinical features, predict visceral leishmaniasis relapse in patients co-infected with HIV
Yegnasew Takele, Tadele Mulaw, Emebet Adem, et al.
Cell Reports Medicine (2021) Vol. 3, Iss. 1, pp. 100487-100487
Open Access | Times Cited: 30
Comparative study on the antileishmanial activities of chemically and biologically synthesized silver nanoparticles (AgNPs)
Ikram Ullah, Gizem Coşar Kutluoğlu, Emrah Şefik Abamor, et al.
3 Biotech (2018) Vol. 8, Iss. 2
Open Access | Times Cited: 38
Immunoinformatics Approach to Design a Multi-Epitope Vaccine against Cutaneous Leishmaniasis
Shumaila Naz, Aiman Aroosh, Ayşe Caner, et al.
Vaccines (2023) Vol. 11, Iss. 2, pp. 339-339
Open Access | Times Cited: 10
Evaluation the biological effect of niosomal hydrogel base amphotericin in combination with Artemisia sieberi essential oil for treatment of cutaneous leishmaniasis: In vitro and in vivo studies
Hanieh Ardeshiri, Amir Hossein Radfar, Gholamreza Hatam, et al.
Results in Chemistry (2025), pp. 102185-102185
Open Access
Investigation of the Anti-Leishmania (Leishmania) infantum Activity of Some Natural Sesquiterpene Lactones
Imke F. Wulsten, Thais A. Costa‐Silva, Juliana Tonini Mesquita, et al.
Molecules (2017) Vol. 22, Iss. 5, pp. 685-685
Open Access | Times Cited: 30
The Potent ITK/BTK Inhibitor Ibrutinib Is Effective for the Treatment of Experimental Visceral Leishmaniasis Caused by Leishmania donovani
Sanjay Varikuti, Greta Volpedo, Noushin Saljoughian, et al.
The Journal of Infectious Diseases (2018) Vol. 219, Iss. 4, pp. 599-608
Open Access | Times Cited: 28
Interleukin-27 Functional Duality Balances Leishmania Infectivity and Pathogenesis
Abdollah Jafarzadeh, Maryam Nemati, Prashant Chauhan, et al.
Frontiers in Immunology (2020) Vol. 11
Open Access | Times Cited: 25
Field-Deployable Treatments For Leishmaniasis: Intrinsic Challenges, Recent Developments and Next Steps
Thalia Pacheco‐Fernández, Hannah L. Markle, Chaitenya Verma, et al.
Research and Reports in Tropical Medicine (2023) Vol. Volume 14, pp. 61-85
Open Access | Times Cited: 9
Lipid bodies accumulation in Leishmania infantum -infected C57BL/6 macrophages
Nilda E. Rodríguez, Ryan D. Lockard, Elizabeth Turcotte, et al.
Parasite Immunology (2017) Vol. 39, Iss. 8
Open Access | Times Cited: 26
Epidemiological and Experimental Evidence for Sex-Dependent Differences in the Outcome of Leishmania infantum Infection
Nilda E. Rodríguez, Iraci Duarte de Lima, Upasna Gaur Dixit, et al.
American Journal of Tropical Medicine and Hygiene (2017) Vol. 98, Iss. 1, pp. 142-145
Open Access | Times Cited: 25
Effects of terpenes in the treatment of visceral leishmaniasis: A systematic review of preclinical evidence
Vagner Dias Raimundo, Renner Philipe Rodrigues Carvalho, Mariana Machado‐Neves, et al.
Pharmacological Research (2022) Vol. 177, pp. 106117-106117
Open Access | Times Cited: 13
The IL-33/ST2 Axis in Immune Responses Against Parasitic Disease: Potential Therapeutic Applications
Nathan Ryan, Kelvin Anderson, Greta Volpedo, et al.
Frontiers in Cellular and Infection Microbiology (2020) Vol. 10
Open Access | Times Cited: 20
The importance of T cell-derived cytokines in post-kala-azar dermal leishmaniasis
Abdollah Jafarzadeh, Sara Jafarzadeh, Iraj Sharifi, et al.
Cytokine (2020) Vol. 147, pp. 155321-155321
Closed Access | Times Cited: 17
<p>Intracellular anti-leishmanial effect of Spergulin-A, a triterpenoid saponin of <em>Glinus oppositifolius</em></p>
Saswati Banerjee, Niladri Mukherjee, Rahul L. Gajbhiye, et al.
Infection and Drug Resistance (2019) Vol. Volume 12, pp. 2933-2942
Open Access | Times Cited: 17
Antileishmanial activity and immunomodulatory effect of secosubamolide, a butanolide isolated from Nectandra oppositifolia (Lauraceae)
Thais A. Costa‐Silva, Geanne A. Alves Conserva, Andrés Jimenez Galisteo, et al.
˜The œJournal of venomous animals and toxins including tropical diseases (2019) Vol. 25
Open Access | Times Cited: 14
Dissecting pathways to thrombocytopenia in a mouse model of visceral leishmaniasis
Gulab Fatima Rani, Olivier Preham, Helen Ashwin, et al.
Blood Advances (2021) Vol. 5, Iss. 6, pp. 1627-1637
Open Access | Times Cited: 12
Recurrent visceral leishmaniasis relapses in HIV co-infected patients are characterized by less efficient immune responses and higher parasite load
Yegnasew Takele, Tadele Mulaw, Emebet Adem, et al.
iScience (2022) Vol. 26, Iss. 2, pp. 105867-105867
Open Access | Times Cited: 9
A Therapeutic Approach Against Leishmania donovani by Predicting RNAi Molecules Against the Surface Protein, gp63
Farhana Tasnim Chowdhury, Mohammad Umer Sharif Shohan, Tasmia Islam, et al.
Current Bioinformatics (2018) Vol. 14, Iss. 6, pp. 541-550
Closed Access | Times Cited: 13
Page 1 - Next Page

Scroll to top